These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 368787)

  • 21. Shortening of the bleeding time in rabbits by hydrocortisone caused by inhibition of prostacyclin generation by the vessel wall.
    Blajchman MA; Senyi AF; Hirsh J; Surya Y; Buchanan M; Mustard JF
    J Clin Invest; 1979 May; 63(5):1026-35. PubMed ID: 376547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DDAVP stimulates prostacyclin production.
    Belch JJ; Small M; McKenzie F; Hill PA; Lowe GD; McIntyre DE; Forbes CD; Prentice CR
    Thromb Haemost; 1982 Apr; 47(2):122-3. PubMed ID: 6808693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasminogen-activator of the arterial wall in occluded arteries.
    Donner L; Klener P; Vodákowá I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):141-7. PubMed ID: 6157618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease.
    Bykowska K; Letowska M; Sabliński J; Binder BR; Kopeć M; Lopaciuk S
    Acta Haematol Pol; 1994; 25(3):261-8. PubMed ID: 7992599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of the bleeding time to predict the risk of clinical bleeding in patients with uraemia.
    Jaiyesimi AE; Mba EC; Edeki IO
    Cent Afr J Med; 1990 May; 36(5):132-5. PubMed ID: 2261626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered platelet shape change in hereditary gelsolin Asp187Asn-related amyloidosis.
    Kiuru S; Javela K; Somer H; Kekomäki R
    Thromb Haemost; 2000 Mar; 83(3):491-5. PubMed ID: 10744159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cryoprecipitate shortens the bleeding time and reduces bleeding complications in patients with uremia.
    Jubelirer SJ; Janson PA; Weinstein MJ; Deykin D
    Trans Assoc Am Physicians; 1980; 93():182-91. PubMed ID: 6787774
    [No Abstract]   [Full Text] [Related]  

  • 29. Shortening of bleeding time after intranasal administration of 1-deamino-8-D-arginine vasopressin to patients with chronic uremia.
    Rydzewski A; Rowiński M; Myśliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):823-30. PubMed ID: 2436997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia.
    Jara A; Chacón C; Burgos ME; Droguett A; Valdivieso A; Ortiz M; Troncoso P; Mezzano S
    Nephrol Dial Transplant; 2009 Apr; 24(4):1121-9. PubMed ID: 19028757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of the hemostatic system in pathogenesis of atherosclerosis as the main etiology of coronary ischemia] [corrected].
    Lisowski P; Małyszko J; Lisowska A; Czech B; Myśliwiec M; Jackowski R; Hirnle T
    Pol Merkur Lekarski; 2004 May; 16(95):465-7. PubMed ID: 15518428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients.
    Pawlak K; Mysliwiec M; Pawlak D
    Thromb Res; 2008; 122(3):328-35. PubMed ID: 18048089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemostatic abnormalities in renal disease.
    Jubelirer SJ
    Am J Kidney Dis; 1985 May; 5(5):219-25. PubMed ID: 3923828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of uraemic bleeding with conjugated oestrogen.
    Liu YK; Kosfeld RE; Marcum SG
    Lancet; 1984 Oct; 2(8408):887-90. PubMed ID: 6148618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostacyclin-like activity in rat vascular tissues. Fast, long-lasting inhibition by treatment with lysine acetylsalicylate.
    Villa S; de Gaetano G
    Prostaglandins; 1977; 14(6):1117-24. PubMed ID: 341228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions.
    Fernandez F; Goudable C; Sie P; Ton-That H; Durand D; Suc JM; Boneu B
    Br J Haematol; 1985 Jan; 59(1):139-48. PubMed ID: 3918557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood coagulation and platelet function following maximal exercise: effects of beta-adrenoceptor blockade.
    Small M; Tweddel AC; Rankin AC; Lowe GD; Prentice CR; Forbes CD
    Haemostasis; 1984; 14(3):262-8. PubMed ID: 6147300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unbalanced prostaglandin synthesis and plasma factors in uraemic bleeding. A hypothesis.
    Remuzzi G; Livio M; Cavenaghi AE; Marchesi D; Mecca G; Donati MB; de Gaetano G
    Thromb Res; 1978 Sep; 13(3):531-6. PubMed ID: 369029
    [No Abstract]   [Full Text] [Related]  

  • 39. Factor VIII complex in uraemia and effects of haemodialysis.
    Turney JH; Woods HF; Fewell MR; Weston MJ
    Br Med J (Clin Res Ed); 1981 May; 282(6277):1653-6. PubMed ID: 6786417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localisation and stimulation of prostacyclin production in vascular cells.
    MacIntyre DE; Pearson JD; Gordon JL
    Nature; 1978 Feb; 271(5645):549-51. PubMed ID: 340965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.